Aripiprazole for schizophrenia.

@article{Elsayeh2004AripiprazoleFS,
  title={Aripiprazole for schizophrenia.},
  author={Hany George El-sayeh and Carla Morganti},
  journal={The Cochrane database of systematic reviews},
  year={2004},
  volume={2},
  pages={CD004578}
}
BACKGROUND Treatment of people with schizophrenia using older typical antipsychotic drugs such as haloperidol can be problematic. Many fail to respond and more experience disabling adverse effects. Aripiprazole is said to be one of a new generation of atypical antipsychotics with good antipsychotic properties and minimal adverse effects. OBJECTIVES To evaluate the effects of aripiprazole for people with schizophrenia and schizophrenia-like psychoses. SEARCH STRATEGY The reviewers searched… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry • 2012
View 6 Excerpts
Highly Influenced

Aripiprazole versus other atypical antipsychotics for schizophrenia.

The Cochrane database of systematic reviews • 2014

Similar Papers

Loading similar papers…